98
Participants
Start Date
May 5, 2022
Primary Completion Date
February 26, 2025
Study Completion Date
December 23, 2032
INCB000928
INCBG000928 will be administered QD orally.
Placebo
Placebo will be administered QD orally.
RECRUITING
Instituto Nacional de Rehabilitacion Luis Guillermo Ibarra, Tlalpan
WITHDRAWN
Ospedale Pediatrico G. Gaslini, Genova
RECRUITING
Children'S Hospital of Philadelphia, Philadelphia
ACTIVE_NOT_RECRUITING
Penn Medicine - Perelman Center For Advanced Medicine, Philadelphia
RECRUITING
Hospital Universitario Ramon Y Cajal, Madrid
RECRUITING
Uniklinik Koln, Cologne
RECRUITING
Mayo Clinic Rochester, Rochester
RECRUITING
Ap-Hp Hopital Lariboisiere, Paris
RECRUITING
Hopital Necker-Enfants Malades, Paris
WITHDRAWN
University of California San Francisco Medical Center, San Francisco
RECRUITING
Beijing Childrens Hospital Capital Medical University, Beijing
RECRUITING
Tongji Hospital of Tongji University, Shanghai
RECRUITING
Shanghai Childrens Medical Center, Shanghai
RECRUITING
Childrens Hospital of Fudan University, Shanghai
RECRUITING
Centro de Estudios Reumatologicos, Santiago
NOT_YET_RECRUITING
Hospital Italiano de Buenos Aires, Ciudad Autonoma Buenos Aires
COMPLETED
Royal North Shore Hospital, St Leonards
RECRUITING
Murdoch Children'S Research Institute, Parkville
RECRUITING
Albert Einstein Israelite Hospital, São Paulo
ACTIVE_NOT_RECRUITING
University Health Network Toronto General Hospital, Toronto
RECRUITING
Policlinico Universitario Agostino Gemelli Universita Cattolica Del Sacro Cuore, Rome
RECRUITING
Amsterdam Umc - Vu Medisch Centrum (Vumc), Amsterdam
RECRUITING
Starship Childrens Hospital, Auckland
RECRUITING
Groote Schuur Hospital Radiation Oncology, Cape Town
ACTIVE_NOT_RECRUITING
Seoul National University Hospital, Seoul
WITHDRAWN
Royal Manchester Childrens Hospital - Department of Paediatric Endocrinology, Manchester
RECRUITING
Royal National Orthopaedic Hospital, Stanmore
Lead Sponsor
Incyte Corporation
INDUSTRY